Efficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma

Name: Efficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma
Published: 2004
License: Public Domain

Novartis Pharmaceuticals · 2004

ClinicalTrials.gov · Datasets · License: Public Domain · 2004

Open Source ↗

asthma

asthma, allergic, atopic, omalizumab, immunoglobulin e, ige, anti-ige, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Efficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma

Related documents